Dying cells actively regulate adaptive immune responses

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nature reviews. Immunology

• Publication date

  2017-03-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nri.2017.9PMID 28287107
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Death

  2018cited by this paper
• Interleukin 33 is a guardian of barriers and a local alarmin

  2016cited by this paper
• Inflammasomes: mechanism of assembly, regulation and signalling

  2016cited by this paper
• Cell death and inflammation: the case for IL‐1 family cytokines as the canonical DAMPs of the immune system

  2016cited by this paper
• Erythropoeitin Signaling in Macrophages Promotes Dying Cell Clearance and Immune Tolerance.

  2016cited by this paper
• An evolutionary perspective on the necroptotic pathway.

  2016cited by this paper
• IL-33 in T Cell Differentiation, Function, and Immune Homeostasis.

  2016cited by this paper
• STING Requires the Adaptor TRIF to Trigger Innate Immune Responses to Microbial Infection.

  2016cited by this paper
• Autophagy proteins in antigen processing for presentation on MHC molecules

  2016cited by this paper
• The Dynamics of Apoptotic Cell Clearance.

  2016cited by this paper
• Programmed Necrosis in the Cross Talk of Cell Death and Inflammation

  2016cited by this paper
• Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity.

  2016cited by this paper
• Necroptosis and Inflammation.

  2016cited by this paper
• Faculty Opinions recommendation of The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis.

  2015cited by this paper
• RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells

  2015cited by this paper
• Ppm1b negatively regulates necroptosis through dephosphorylating Rip3

  2015cited by this paper
• Programmed necrosis in the cross talk of cell death and inflammation.

  2015cited by this paper
• Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death

  2015cited by this paper
• Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling

  2015cited by this paper
• The diverse role of RIP kinases in necroptosis and inflammation

  2015cited by this paper
• The ubiquitin-modifying enzyme A20 restricts the ubiquitination of RIPK3 and protects cells from necroptosis

  2015cited by this paper
• The two faces of receptor interacting protein kinase-1.

  2014cited by this paper
• Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors

  2014cited by this paper
• The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response

  2014cited by this paper
• ASC has extracellular and prionoid activities that propagate inflammation

  2014cited by this paper
• Mechanisms and functions of inflammasomes.

  2014cited by this paper
• Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

  2014cited by this paper
• Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production.

  2014cited by this paper
• A long-awaited merger of the pathways mediating host defence and programmed cell death

  2014cited by this paper
• Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA.

  2014cited by this paper
• Red blood cells induce necroptosis of lung endothelial cells and increase susceptibility to lung inflammation.

  2014cited by this paper
• Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3.

  2014cited by this paper
• RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis

  2014cited by this paper
• The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism.

  2013cited by this paper
• Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis

  2013cited by this paper
• Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death

  2013cited by this paper
• The transcription factor IRF3 triggers "defensive suicide" necrosis in response to viral and bacterial pathogens.

  2013cited by this paper
• Molecular mechanisms of T cell co-stimulation and co-inhibition

  2013cited by this paper
• Fas/CD95-induced chemokines can serve as "find-me" signals for apoptotic cells.

  2013cited by this paper
• Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8

  2013cited by this paper
• The impact of macroautophagy on CD8+ T‐cell‐mediated antiviral immunity

  2013cited by this paper
• An Updated View of the Intracellular Mechanisms Regulating Cross-Presentation

  2013cited by this paper
• Heat‐shock proteins as dendritic cell‐targeting vaccines – getting warmer

  2013cited by this paper
• Adaptive immunity after cell death.

  2013cited by this paper
• Peptidases released by necrotic cells control CD8+ T cell cross-priming.

  2013cited by this paper
• Pathways of antigen processing.

  2013cited by this paper
• The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis.

  2012cited by this paper
• DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA.

  2012cited by this paper
• HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease

  2012cited by this paper
• The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice.

  2012cited by this paper
• IL-1R signaling in dendritic cells replaces pattern recognition receptors to promote CD8+ T cell responses to influenza A virus

  2012cited by this paper
• The Role of Heat Shock Proteins in Antigen Cross Presentation

  2012cited by this paper
• Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase.

  2012cited by this paper
• PIDD death-domain phosphorylation by ATM controls prodeath versus prosurvival PIDDosome signaling.

  2012cited by this paper
• PAMPs and DAMPs: signal 0s that spur autophagy and immunity

  2012cited by this paper
• Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis

  2012cited by this paper
• The danger theory in view of the injury hypothesis: 20 years later

  2012cited by this paper
• F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells.

  2012cited by this paper
• Dendritic cells sequester antigenic epitopes for prolonged periods in the absence of antigen-encoding genetic information

  2012cited by this paper
• Exogenous, TAP‐independent lysosomal presentation of a respiratory syncytial virus CTL epitope

  2012cited by this paper
• The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments.

  2012cited by this paper
• A perspective on mammalian caspases as positive and negative regulators of inflammation.

  2012cited by this paper
• cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms

  2011cited by this paper
• RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein.

  2011cited by this paper
• Dying to replicate: the orchestration of the viral life cycle, cell death pathways, and immunity.

  2011cited by this paper
• The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs.

  2011cited by this paper
• Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice

  2011cited by this paper
• Tumor-Derived Autophagosome Vaccine: Mechanism of Cross-Presentation and Therapeutic Efficacy

  2011cited by this paper
• Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response

  2011cited by this paper
• Inflammatory cytokines as a third signal for T cell activation.

  2010cited by this paper
• Decoding cell death signals in inflammation and immunity.

  2010cited by this paper
• Cross-priming in health and disease

  2010cited by this paper
• Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis

  2010cited by this paper
• Inducible Dimerization and Inducible Cleavage Reveal a Requirement for Both Processes in Caspase-8 Activation*

  2010cited by this paper
• Structure of an apoptosome-procaspase-9 CARD complex.

  2010cited by this paper
• Immunogenic death of colon cancer cells treated with oxaliplatin

  2010cited by this paper
• Caspase-mediated cleavage, IAP binding, and ubiquitination: linking three mechanisms crucial for Drosophila NF-kappaB signaling.

  2010cited by this paper
• Mitochondria and cell death: outer membrane permeabilization and beyond

  2010cited by this paper
• Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance

  2009cited by this paper
• Immunogenic and tolerogenic cell death

  2009cited by this paper
• Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells

  2009cited by this paper
• Death receptor signal transducers: nodes of coordination in immune signaling networks

  2009cited by this paper
• Identification of a dendritic cell receptor that couples sensing of necrosis to immunity

  2009cited by this paper
• RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis

  2009cited by this paper
• Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

  2009cited by this paper
• Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha.

  2009cited by this paper
• Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

  2009cited by this paper
• DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF‐κB

  2009cited by this paper
• Identification of RIP1 kinase as a specific cellular target of necrostatins.

  2008cited by this paper
• Efficient cross-presentation depends on autophagy in tumor cells.

  2008cited by this paper
• TRADD protein is an essential component of the RIG-like helicase antiviral pathway.

  2008cited by this paper
• Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein.

  2008cited by this paper
• How dying cells alert the immune system to danger

  2008cited by this paper
• Antigen Persistence Is Required for Dendritic Cell Licensing and CD8+ T Cell Cross-Priming1

  2008cited by this paper
• A phylogenetic and functional overview of inflammatory caspases and caspase-1-related CARD-only proteins.

  2007cited by this paper
• Calreticulin exposure dictates the immunogenicity of cancer cell death

  2007cited by this paper
• Caspase substrates

  2007cited by this paper
• Cross-presentation of caspase-cleaved apoptotic self-antigens in HIV infection

  2007cited by this paper
• The antiapoptotic activity of insect IAPs requires activation by an evolutionarily conserved mechanism

  2007cited by this paper
• Triggering of Dendritic Cell Responses after Exposure to Activated, but Not Resting, Apoptotic PBMCs1

  2007cited by this paper

• Microfluidic-Assisted Metal-Polyphenol Cloaked Bacteria Enable CRISPR/dCas9-Mediated Pyroptosis Cascade Amplification for Effective Tumor Immunotherapy.

  2026cites this paper
• Overcoming Biological Barriers with a Microwave-Sensitizing Nanomotor for Empowering Microwave Thermal Immunotherapy.

  2026cites this paper
• A metal-immuno photosensitizer strategy: Iridium(III)-zidovudine conjugate triggering sequential organelle stress and synergizing with PD-L1 inhibitor in oral squamous cell carcinoma

  2026cites this paper
• Current Advancements in the Arsenal for Spinal Cord Injury Repair: Novel Drug Formulations.

  2026cites this paper
• Deep immune-phenotyping of HLA-homozygous iPS-cardiomyocytes by spectral flow cytometry.

  2026cites this paper
• Dietary Polyphenols Curcumin and Resveratrol Exert Selective Anticancer Effects in Melanoma Cells

  2026cites this paper
• “Cancer-treating-cancer” strategy: Entrapping engineered dying cancer cells in immunotherapeutic hydrogel against tumor recurrence

  2025cites this paper
• Targeting regulated cell death: Apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity

  2025cites this paper
• Targeting the Met-RIPK1 signaling axis to enforce apoptosis and necroptosis in colorectal cancer

  2025cites this paper
• Regulated cell death and DAMPs as biomarkers and therapeutic targets in normothermic perfusion of transplant organs. Part 2: implementation strategies

  2025cites this paper
• Optogenetically Activatable MLKL as a Standalone Functional Module for Necroptosis and Therapeutic Applications in Antitumoral Immunity

  2025cites this paper
• In situ non-canonical activation and sensitization of cGAS-STING pathway with manganese telluride nanosheets.

  2025cites this paper
• Remodeling Tumor Metabolism via Self‐Amplifying Energy‐Depleting Nanocomplexes for Effective Photodynamic‐Immunotherapy

  2025cites this paper
• Pyroptosis in Acute Pancreatitis: From Pathogenesis to Treatment.

  2025cites this paper
• Circulating RIPK3 level predicts all-cause mortality in patients on maintenance hemodialysis: a 4-year prospective cohort study

  2025cites this paper
• Recent advances in antitumor Pt(IV) complexes: Dual targeting and chemoimmunotherapy

  2025cites this paper
• AND-gated protease-activated nanosensors for programmable detection of anti-tumour immunity

  2025cites this paper
• [Machine learning-based programmed cell death signature model for precise prediction of prognosis and treatment response in melanoma].

  2025cites this paper
• Bioengineered Nanozymes for Orthopedic Degenerative Diseases: From Catalytic Mechanisms to Multimodal Therapy

  2025cites this paper
• Saponin-mediated cell membrane interference nanomedicine potentiates tumor chemo-immunotherapy via a perforin-granzyme-like mechanism.

  2025cites this paper
• Single cell RNA sequencing to identify an Immunogenic cell death related prognostic signature in intrahepatic cholangiocarcinoma

  2025cites this paper
• Harnessing Immunogenic Cell Death to Boost the Impact of Radiation Therapy.

  2025cites this paper
• The Research Progress of T Lymphocytes in Myocardial Infarction.

  2025cites this paper
• Overcoming resistant cancerous tumors through combined photodynamic and immunotherapy (photoimmunotherapy)

  2025cites this paper
• Boosting Dendritic Cell Function in Cancer

  2025cites this paper
• Immunogenic Cell Death Genes Related Prognostic Biomarker in Hepatocellular Carcinoma

  2025cites this paper
• Oncolytic virus and immunogenic cell death in cancer therapy

  2025cites this paper
• Biomimetic Self-Guiding Nanomotors Boost Active Immunotherapy.

  2025cites this paper
• Dual-targeted fucoidan-TPP nanoparticles delivery system potently inhibit breast cancer via mitochondrial dysfunction and cGAS-STING activation.

  2025cites this paper
• Exosomal Pparα derived from cancer cells induces CD8+ T cell exhaustion in hepatocellular carcinoma through the miR-27b-3p/TOX axis

  2025cites this paper
• Bioactive metallic nanoparticles for synergistic cancer immunotherapy

  2025cites this paper
• Dying to survive: harnessing inflammatory cell death for better immunotherapy.

  2025cites this paper
• Metal-based immunogenic cell death inducers for cancer immunotherapy

  2025cites this paper
• Activation of the Coagulation Cascade as a Universal Danger Sign

  2025cites this paper
• MLKL–Mediated Necroptosis Predominantly Contributes to Immune-Associated Myocardial Damage

  2025cites this paper
• Nucleic Acid‐Locked Smart Carrier for Photothermal/Chemotherapy‐Amplified Immunogenic Cell Death to Enhance Systemic Antitumor Efficacy

  2025cites this paper
• Caerin 1.1 and 1.9 peptides induce acute caspase 3/GSDME-mediated pyroptosis in epithelial cancer cells

  2025cites this paper
• Trojan horse natural killer cells enhance targeted drug delivery and boost memory T cell-mediated immune responses in triple-negative breast cancer.

  2025cites this paper
• Regulated cell death and DAMPs as biomarkers and therapeutic targets in normothermic perfusion of transplant organs. Part 1: their emergence from injuries to the donor organ

  2025cites this paper
• Multifunctional hydrogels: Therapeutic strategies and advances in inflammation

  2025cites this paper
• Interplay between cancer-associated fibroblasts and dendritic cells: implications for tumor immunity

  2025cites this paper
• Mitigating radioresistance mechanisms by polymer-lipid manganese dioxide nanoparticles enhances immunogenic cell death and antitumor immune response to facilitate abscopal effect in breast tumor models

  2025cites this paper
• Short-term high-dose gemcitabine induces PERK-mediated immunogenic cell death and potentiates antitumor immunity in bladder cancer.

  2025cites this paper
• Inhibition of polymorphonuclear cells averts cytotoxicity against hypoimmune cells in xenotransplantation

  2025cites this paper
• Organoplatinum(II) Type II Immunogenic Cell Death Inducers Target Protein Tyrosine Phosphatase 1B to Drive Immunogenicity

  2025cites this paper
• Kaempferol enhances immunogenic cell death via premortem stress and necroptosis in cholangiocarcinoma: Insights from network pharmacology and mechanistic studies

  2025cites this paper
• Vaccine adjuvants as stand-alone immunoprophylaxis in strategies for 100-day rapid responses to future pandemics.

  2025cites this paper
• Chiral nanoassembly remodels tumor microenvironment through non-oxygen-dependent depletion lactate for effective photodynamic immunotherapy.

  2025cites this paper
• Macrocarpal I induces immunogenic cell death and synergizes with immune checkpoint inhibition by targeting tubulin and PARP1 in colorectal cancer

  2025cites this paper
• Identification of a fungal antibacterial endopeptidase that cleaves peptidoglycan

  2025cites this paper
• Reprogramming RIPK3-induced cell death in malignant B cells promotes immune-mediated tumor control

  2025cites this paper
• Drug-Free Approach to Regulate Undruggable Proto-Oncogene MYC Using Biomimetic Porous Nanoparticles for Cancer Immunotherapy.

  2025cites this paper
• Lipid nanoparticles as a tool to dissect dendritic cell maturation pathways

  2025cites this paper
• Interplay between survival and regulated cell death mechanisms during periodontitis progression: a systematic review

  2025cites this paper
• For Better or Worse: The Impact of Necrotic Cell Death Modalities.

  2025cites this paper
• 13th Tuscany Retreat on Cancer Research and Apoptosis: Genetic profiling, resistance mechanisms and novel treatment concepts in cancer and neurodegeneration.

  2025cites this paper
• Targeting tumor intrinsic TAK1 engages TNF-α-driven cell death through distinct mechanisms and enhances cancer immunotherapy

  2025cites this paper
• Exploratory Research for HIF-1α Overexpression Tumor Antigen in the Activation of Dendritic Cells and the Potent Anti-Tumor Immune Response

  2024cites this paper
• Pyruvate Kinase M2‐Responsive Release of Paclitaxel and Indoleamine 2,3‐Dioxygenase Inhibitor for Immuno‐Chemotherapy of Nonsmall Cell Lung Cancer

  2024cites this paper
• Nanoformula Design for Inducing Non‐Apoptotic Cell Death Regulation: A Powerful Booster for Cancer Immunotherapy

  2024cites this paper
• Cytokine-armed pyroptosis induces antitumor immunity against diverse types of tumors

  2024cites this paper
• Targeting cuproptosis with nano material: new way to enhancing the efficacy of immunotherapy in colorectal cancer

  2024cites this paper
• Triggering immunogenic death of cancer cells by nanoparticles overcomes immunotherapy resistance

  2024cites this paper
• Biomimetic etoposide-loaded PLGA nanoparticles induce immunogenic cell death against colorectal cancer

  2024cites this paper
• Constitutive DAMPs in CNS injury: From preclinical insights to clinical perspectives.

  2024cites this paper
• Flow cytometry-assisted analysis of phenotypic maturation markers on an immortalized dendritic cell line.

  2024cites this paper
• Intrinsic immunomodulatory hydrogels for chronic inflammation.

  2024cites this paper
• NIR-activated Janus nanomotors with promoted tumor permeability for synergistic photo-immunotherapy.

  2024cites this paper
• Cytomegalovirus Biology Viewed Through a Cell Death Suppression Lens

  2024cites this paper
• Polysulfonium: Unveiling a Bioactive Polymer to Induce Immunogenic Cell Death for Anticancer Therapy.

  2024cites this paper
• Interference of ATP‐Adenosine Axis by Engineered Biohybrid for Amplifying Immunogenic Cell Death‐Mediated Antitumor Immunotherapy

  2024cites this paper
• Restore Intestinal Barrier Integrity: An Approach for Inflammatory Bowel Disease Therapy

  2024cites this paper
• A trinity Strategy: Mesoporous platinum nanoparticles serve as a photoenhanced nanoplatform for tumor immunotherapy

  2024cites this paper
• A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death.

  2024cites this paper
• Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination.

  2024cites this paper
• Regulation of NLRPs by reactive oxygen species: A story of crosstalk.

  2024cites this paper
• The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma.

  2024cites this paper
• PANoptosis-related genes function as efficient prognostic biomarkers in colon adenocarcinoma

  2024cites this paper
• Enhancing cancer immunotherapy with photodynamic therapy and nanoparticle: making tumor microenvironment hotter to make immunotherapeutic work better

  2024influential citation
• Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity

  2024influential citation
• Epigenetic Priming by Hypomethylation Enhances the Immunogenic Potential of Tolinapant in T-cell Lymphoma

  2024cites this paper
• Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma

  2024cites this paper
• Apoptotic cell mimics enhance immunogenic cell death and inflame tumor microenvironment by modulating macrophages

  2024cites this paper
• Nanomedicine-induced cell pyroptosis to enhance antitumor immunotherapy.

  2024cites this paper
• Vaccine adjuvants: Tailoring innate recognition to send the right message.

  2024cites this paper
• Advances in therapeutic cancer vaccines: Harnessing immune adjuvants for enhanced efficacy and future perspectives

  2024cites this paper
• Nanocatalysts for modulating antitumor immunity: fabrication, mechanisms and applications.

  2024cites this paper
• Multifactoral immune modulation potentiates durable remission in multiple models of aggressive malignancy

  2024cites this paper
• mRNA vaccines contribute to innate and adaptive immunity to enhance immune response in vivo.

  2024cites this paper
• Sensitize Tumor Immunotherapy: Immunogenic Cell Death Inducing Nanosystems

  2024cites this paper
• Enhancing cancer therapy: the integration of oncolytic virus therapy with diverse treatments

  2024cites this paper
• Two-pronged anti-cancer nanovaccines enpowered by exogenous/endogenous tumor-associated antigens.

  2024cites this paper
• Impact of Genomic Mutation on Melanoma Immune Microenvironment and IFN-1 Pathway-Driven Therapeutic Responses

  2024cites this paper
• Developmental endothelial locus 1: the present and future of an endogenous factor in vessels

  2024cites this paper
• A homologous-targeting cGAS-STING agonist multimodally activates dendritic cells for enhanced cancer immunotherapy.

  2024cites this paper
• Ferroptosis: a dual-edged sword in tumour growth

  2024cites this paper
• Combination of vitamin D and photodynamic therapy enhances immune responses in murine models of squamous cell skin cancer.

  2024cites this paper
• SOCS1 expression in cancer cells: potential roles in promoting antitumor immunity

  2024cites this paper
• Employing Piezoelectric Mg2+‐Doped Hydroxyapatite to Target Death Receptor‐Mediated Necroptosis: A Strategy for Amplifying Immune Activation

  2024cites this paper
• Recent advances in the metal/organic hybrid nanomaterials for cancer theranostics

  2024cites this paper